Reply
Masakatsu Motomura MD
First Department of Internal Medicine, Nagasaki University School of Medicine, Nagasaki, Japan
Search for more papers by this authorTaku Fukuda MD
First Department of Internal Medicine, Nagasaki University School of Medicine, Nagasaki, Japan
Search for more papers by this authorYoko Nakao MD
First Department of Internal Medicine, Nagasaki University School of Medicine, Nagasaki, Japan
Nagasaki Kita Hospital, Nagasaki, Japan
Search for more papers by this authorHirokazu Shiraishi MD
First Department of Internal Medicine, Nagasaki University School of Medicine, Nagasaki, Japan
Search for more papers by this authorToshiro Yoshimura MD
School of Health Sciences, Nagasaki University, Nagasaki, Japan
Search for more papers by this authorHirotoshi Desaka-Akita MD
Department of Medical Oncology, Hokkaido University Graduate of Medicine, Sapporo, Japan
Search for more papers by this authorKatsumi Eguchi MD
First Department of Internal Medicine, Nagasaki University School of Medicine, Nagasaki, Japan
Search for more papers by this authorMasakatsu Motomura MD
First Department of Internal Medicine, Nagasaki University School of Medicine, Nagasaki, Japan
Search for more papers by this authorTaku Fukuda MD
First Department of Internal Medicine, Nagasaki University School of Medicine, Nagasaki, Japan
Search for more papers by this authorYoko Nakao MD
First Department of Internal Medicine, Nagasaki University School of Medicine, Nagasaki, Japan
Nagasaki Kita Hospital, Nagasaki, Japan
Search for more papers by this authorHirokazu Shiraishi MD
First Department of Internal Medicine, Nagasaki University School of Medicine, Nagasaki, Japan
Search for more papers by this authorToshiro Yoshimura MD
School of Health Sciences, Nagasaki University, Nagasaki, Japan
Search for more papers by this authorHirotoshi Desaka-Akita MD
Department of Medical Oncology, Hokkaido University Graduate of Medicine, Sapporo, Japan
Search for more papers by this authorKatsumi Eguchi MD
First Department of Internal Medicine, Nagasaki University School of Medicine, Nagasaki, Japan
Search for more papers by this author
References
- 1 Fukuda T, Motomura M, Nakao Y, et al. Reduction of P/Q-type calcium channels in the postmortem cerebellum of paraneoplastic cerebellar degeneration with Lambert-Eaton myasthenic syndrome. Ann Neurol 2003; 53: 21–28.
- 2 Mason WP, Graus F, Lang B, et al. Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome. Brain 1997; 120: 1279–1300.
- 3 Motomura M, Lang B, Johnston I, et al. Incidence of serum anti-P/O-type and anti-N-type calcium channel autoantibodies in the Lambert-Eaton myasthenic syndrome. J Neurol Sci 1997; 147: 35–42.